ARV Procurement Working Group Newsletters
A framework to support new product introduction in national health systems
Resource Library
- Dec 16, 2022
2022 HIV Market Report
- Dec 8, 2022
Mental Health and Psychosocial Wellbeing Manual and Workbook
- Oct 18, 2022
Prevention Product Preference Brief
- Oct 18, 2022
CAB-LA Community Meeting Overview
- Sep 12, 2022
AHD Community Advocacy Video
- Sep 12, 2022
Pediatric DTG Advocacy Video for Communities (English and French)
- Jul 31, 2022
Optimal CAB Case Study: Enabling and Ensuring Equitable HIV Treatment for Women
- Jul 31, 2022
Case Study: Community-Developed HIV Care and Treatment Literacy Improves Uptake of Optimal Medicines
- Jul 10, 2022
APWG Anticipated Demand Forecast
- Jun 23, 2022
EGPAF Guidance and Algorithm for Follow-Up of Children After Starting or Transitioning to pDTG
- Jun 16, 2022
AHD Social Media Campaign
- May 31, 2022
2022 CHAI HIV Mid-Year Market Memo
- May 24, 2022
GAP-f pDTG Implementation Considerations for National Programmes
- May 10, 2022
CHAI ARV Benchmark Price Comparison List
- Apr 27, 2022
Pediatric DTG Administration Video for Caregivers (English and French)
- Apr 13, 2022
Adult DRV/r (400/50mg) FAQs for Communities and PLHIV
- Apr 4, 2022
Pediatric DTG Poster (English, French, Swahili)
- Apr 4, 2022
Pediatric DTG FAQs for Caregivers and Communities (English, French, Swahili)
- Apr 4, 2022
Pediatric DTG Administration Poster for Caregivers (English, French, Swahili)